Power and sample size calculations for discrete bounded outcome scores

Statistics in Medicine

Volumn 25, Issue 24, 2006, Pages 4241-4252

  Tsonaka, Roula ^a   Rizopoulos, Dimitris ^a   Lesaffre, Emmanuel ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Barthel index; Bounded outcome scores; Grouped data; Power; Sample size calculations

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; HEALTH STATISTICS; HUMAN; MONTE CARLO METHOD; NORMAL DISTRIBUTION; OUTCOME ASSESSMENT; PARAMETRIC TEST; POWER ANALYSIS; SAMPLE SIZE; SCORING SYSTEM; STATISTICAL MODEL; THERAPY EFFECT;

CEREBROVASCULAR ACCIDENT; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FIBRINOLYTIC AGENTS; HUMANS; MONTE CARLO METHOD; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SAMPLE SIZE;

EID: 33845907437     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2679     Document Type: Article

References (18)

1. Heitjan D, Rubin D. Ignorability and coarse data. Annals of Statistics 1991; 19:2244-2253.
2. Heitjan D. Ignorability and coarse data: some biomedical examples. Biometrics 1993; 49:1099-1109.
3. Noether GE. Sample size determination for some common nonparametric tests. Journal of the American Statistical Association 1987; 82:645-647.
4. Walters SJ, Campbell MJ. The use of bootstrap methods for estimating sample size and analysing health-related quality of life outcomes. Statistics in Medicine 2005; 24:1075-1102.
5. van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bulletin of the International Statistical Institute 1960; 37:351-361.
6. Lesaffre E, Scheys I, Fröhlich J, Bluhmki E. Calculation of power and sample size with bounded outcome scores. Statistics in Medicine 1993; 12:1063-1078.
7. Lesaffre E, de Klerk E. Estimating the power of compliance - improving methods. Control Clinical Trials 2000; 21:540-551.
8. Tsodikov A, Hasenclever D, Loeffler D. Regression with bounded outcome score: evaluation of power by bootstrap and simulation in a chronic myelogenous leukaemia clinical trial. Statistics in Medicine 1998; 17:1909-1922.9 Collings BJ, Hamilton MA. Estimating the power of the two sample Wilcoxon test for location shift. Biometrics 1988; 44:847-860.
9. Collings BJ, Hamilton MA. Estimating the power of the two sample Wilcoxon test for location shift. Biometrics 1988; 44:847-860.
10. Hamilton MA, Collings BJ. Determining the appropriate sample size for nonparametric tests for location shift. Technometrics 1991; 3:327-337.
11. Lesaffre E, Rizopoulos D, Tsonaka R. The logistic-transformation for bounded outcome scores. Biostatistics 2006, in press. doi: 10.1093/ biostatistics/kxj034.
12. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 1999; 30:2631-2636.
13. Aitchison J, Shen S. Logistic-normal distributions: some properties and uses. Biometrika 1980; 67:261-272.
14. Tsonaka R, Rizopoulos D, Lesaffre E. Power and sample size calculations for disrete bounded outcome scores. Technical Report, 2006, url: http://www.stat.ucl.ac.be/ISpub/tr/2005/TR0505.pdf
15. Heeren T, D'Agostino RB. Robustness of the two independent samples t-test when applied to ordinal scaled data. Statistics in Medicine 1987; 6:79-90.
16. Sullivan IM, D'Agostino RB. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Statistics in Medicine 2003; 22:1317-1334.
17. Armitage R, Berry G. Statistical Methods in Medical Research (2nd edn). Blackwell Scientific Publications: Oxford, 1987.
18. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2005. ISBN 3-900051-07-0.